Skip to main content
Log in

Comparative Evaluation of Antiparkinsonian, Anti-Inflammatory, and Analgesic Effects of Hemantane and Two 2-Aminoadamantane Derivatives Differing From it by a Bridgehead Hydroxyl

  • MOLECULAR-BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

2-Adamantylaminopropanol hydrochloride (ADK-971) and 5-hydroxyadamantan-2-ylaminopropanol hydrochloride (ADK-1013) were less active than hemantane in parkinsonian syndrome murine models. ADK-971 and AKD-1013, like hemantane at a dose of 20 mg/kg, exhibited comparable antiexudative effects in the mouse acetic peritonitis model. However, ADK-971 and ADK-1013 (20 mg/kg), in contrast to hemantane at the same dose, did not possess analgesic effects against visceral and thermal somatic pain in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. https://www.rlsnet.ru/mnn index id 2206.htm#primenenie-veshhestva-memantin

  2. https://www.rlsnet.ru/mnn_index_id_289.htm

  3. A. V. Nepoklonov, I. G. Kapitsa, E. A. Ivanova, et al., Eksp. Klin. Farm., 75(11), 3 – 6 (2012).

    CAS  Google Scholar 

  4. E. A. Ivanova, A. V. Nepoklonov, I. I. Kokshenev, et al., Biomeditsina, 1(1), 74 – 81 (2012).

    Google Scholar 

  5. E. A. Ivanova, I. G. Kapitsa, E. A. Val’dman, and T. A. Voronina, Byull. Eksp. Biol. Med., 159(3), 362 – 365 (2015).

    Article  CAS  Google Scholar 

  6. E. A. Katunina, A. V. Petrukhova, G. N. Avakyan, et al., Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 108(6), 24 – 27 (2008).

    CAS  PubMed  Google Scholar 

  7. E. A. Ivanova, I. G. Kapitsa, A. V. Nepoklonov, et al., Khim.- farm. Zh., 47(10), 12 – 15 (2013); Pharm. Chem. J., 47(10), 517 – 520 (2013).

  8. E. A. Ivanova, I. G. Kapitsa, E. A. Valdman, and T. A. Voronina, Adv. Parkinson’s Dis., No. 5, 50 – 60 (2016).

  9. I. G. Kapitsa, E. A. Ivanova, T. A. Voronina, et al., Farmakokinet. Farmakodin., No. 3, 42 – 46 (2016).

  10. RU Pat. Appl. 4,947,575 / 04; Byull. Izobret., No. 4 (2011).

  11. N. I. Avdyunina, I. S. Morozov, et al., RU Pat. 1,746,661, Jan. 10, 1996.

  12. N. V. Klimova, B. M. Pyatin, N. M. Zaitseva, et al., Khim.-farm. Zh., 20(7), 810 – 915 (1986).

    CAS  Google Scholar 

  13. T. A. Voronina, E. A Val’dman, L. N. Nerobkova, and I. G. Kapitsa, Methodical Recommendations for Preclinical Trials of Antiparkinsonian Drugs [in Russian], in: Handbook for Preclinical Drug Trials [in Russian], Part 1, Grif i K, Moscow, 2012, pp. 219 – 234.

  14. J. L. Tillerson and G. W. Miller, J. Neurosci. Methods, 123(2), 189 – 200 (2003).

    Article  PubMed  Google Scholar 

  15. G. Ya. Shvarts and R. D. Syubaev, Methodical Recommendations for Preclinical Trials of Nonsteroidal Anti-Inflammatory Drugs [in Russian], in: Handbook for Preclinical Drug Trials [in Russian], Part 1, Grif i K, Moscow, 2012, pp. 746 – 758.

  16. T. A. Voronina and L. S. Guzevatykh, Methodical Recommendations for Preclinical Trials of Analgesic Drugs [in Russian], in: Handbook for Preclinical Drug Trials [in Russian], Part 1, Grif i K, Moscow, 2012, pp. 197 – 218.

  17. I. G. Kapitsa, I. I. Kokshenev, E. A. Val’dman, and T. A. Voronin, Farmakokinet. Farmakodin., No. 2, 10 – 16 (2012).

Download references

Acknowledgments

The work was sponsored by a State Task on Topic No. 0521-2019-0007.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. A. Ivanova.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 53, No. 5, pp. 3 – 7, May, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kapitsa, I.G., Ivanova, E.A., Avdyunina, N.I. et al. Comparative Evaluation of Antiparkinsonian, Anti-Inflammatory, and Analgesic Effects of Hemantane and Two 2-Aminoadamantane Derivatives Differing From it by a Bridgehead Hydroxyl. Pharm Chem J 53, 383–387 (2019). https://doi.org/10.1007/s11094-019-02009-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-019-02009-9

Keywords

Navigation